Answers are grounded in this paper and cite their sources.
The teratogenic effects of valproate, especially in relation to the formation of cardiac defects, remains a serious problem in pediatric cardiology, as the drug continues to be used in clinical practice in pregnant women. The article presents a clinical case of a child with cardiovascular, skeletal, and renal abnormalities, whose mother received valproic acid during pregnancy. The article analyzes the possible mechanisms of the patient’s congenital malformations, including genetic factors and the induction of teratogenesis by fetal valproate syndrome.
No takes yet. Share an insight, caveat, or question.
Polyakova et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: